1. Bul’on, V.V., Khnychenko, L.K., Sapronov, N.S., Kovalenko, A.L., and Alekseeva, L.E., Correction of consequences of postischemic reperfusion brain damages with cytoflavin, Bull. Expe. Biol. Med., 2000, vol. 129, no. 2, pp. 128–130.
2. Valeev, V.V., Kovalenko, A.L., Talikova, E.V., et al., Biological functions of succinate: overview of foreign experiments, Antibiot. Khimioter., 2015, vol. 60, nos. 9–10, pp. 33–37.
3. Ivnitskii, Yu.Yu., Golovko, A.I., and Sofronov, G.A., Yantarnaya kislota v sisteme sredstv metabolicheskoi korrektsii funktsional’nogo sostoyaniya i rezistentnosti organizma (Succinic Acid as the Mean for Correction of Functional State and Resistance of the Organism), St. Petersburg: Lan’, 1998.
4. Kovalev, G.V., Nootropnye sredstva (Nootropic Medical Drugs), Volgograd: Nizhnevolzhskoe Knizhn. Izd., 1990.
5. Mylnikov, S.V., Regression of survivability variance on the cohort age in Drosophila melanogaster. I. Survivability: reaction norm and its inheritance, Adv. Gerontol., 2018, vol. 8, no. 4, pp. 277–283.